4-phenylsulfonamidopiperidines as calcium channel blockers

Details for Australian Patent Application No. 2005293697 (hide)

Owner Euro-Celtique S.A.

Inventors Chen, Zhengming; Whitehead, John W. F.; Tafesse, Laykea; Sha, Deyou; Benjamin, Elfrida R.; Zhou, Xiaoming; Victory, Samuel F.

Agent FB Rice

Pub. Number AU-A-2005293697

PCT Pub. Number WO2006/040181

Priority 60/618,419 14.10.04 US; 60/694,972 30.06.05 US

Filing date 14 October 2005

Wipo publication date 20 April 2006

International Classifications

C07D 211/58 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61P 29/02 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 211/98 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

7 June 2007 PCT application entered the National Phase

  PCT publication WO2006/040181 Priority application(s): WO2006/040181

8 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005293698-Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

2005293694-Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to madulation of the dopamine D3 receptor